EyePoint Pharmaceuticals (EYPT) Proxy filing summary

Executive summary

• Annual meeting scheduled for June 18, 2026, to be held virtually at 9:00 A.M. Eastern Time.

• Proxy materials and annual report for the year ended December 31, 2025, are available online for review and voting.

• Shareholders are encouraged to vote online or request paper copies of proxy materials by June 8, 2026.

Voting matters and shareholder proposals

• Election of eight directors, with the board recommending a vote for all nominees.

• Approval of Amendment No. 3 to the 2023 Long-Term Incentive Plan to increase authorized shares by 4,900,000.

• Advisory vote on executive compensation for named executive officers.

• Ratification of Deloitte & Touche LLP as independent auditor for fiscal year ending December 31, 2026.

Board of directors and corporate governance

• Board recommends voting for all eight director nominees listed for election.